These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 19081403)

  • 1. Within-person variation of the plasma concentration of B-type natriuretic peptide: safety range in stable patients with heart failure.
    Takeda Y; Takeda Y; Suzuki S; Kimura G
    Am Heart J; 2009 Jan; 157(1):97-101. PubMed ID: 19081403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart failure may be associated with the onset of ischemic stroke with atrial fibrillation: a brain natriuretic peptide study.
    Shibazaki K; Kimura K; Okada Y; Iguchi Y; Terasawa Y; Aoki J
    J Neurol Sci; 2009 Jun; 281(1-2):55-7. PubMed ID: 19321180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-6 and tumor necrosis factor-alpha as biochemical markers of heart failure: a head-to-head clinical comparison with B-type natriuretic peptide.
    Boffa GM; Zaninotto M; Sartor R; Mion M; Berton A; Pasqualetto C; Razzolini R; Plebani M
    J Cardiovasc Med (Hagerstown); 2009 Oct; 10(10):758-64. PubMed ID: 19553828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline and 6-month B-type natriuretic peptide changes are independent predictors of events in patients with advanced heart failure awaiting cardiac transplantation.
    Campana C; Pasotti M; Klersy C; Alessandrino G; Albertini R; Magrini G; Ghio S; Tavazzi L
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):671-6. PubMed ID: 19444135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of the use of B-type natriuretic peptide levels for risk stratification at discharge in elderly patients with decompensated heart failure.
    Cournot M; Mourre F; Castel F; Ferrières J; Destrac S
    Am Heart J; 2008 Jun; 155(6):986-91. PubMed ID: 18513508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of endogenous B-type natriuretic peptide at very low concentrations in patients with heart failure.
    Niederkofler EE; Kiernan UA; O'Rear J; Menon S; Saghir S; Protter AA; Nelson RW; Schellenberger U
    Circ Heart Fail; 2008 Nov; 1(4):258-64. PubMed ID: 19808300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy optimization of heart failure through the evaluation of the plasma concentration variation of B-type natriuretic peptide].
    Coppola A; De Paola G; Suppa M; Maggi B; Giancaspro G; Colzi M; Scarpellini MG; Lacenere L; Gerratana G; Aguglia F
    Clin Ter; 2006; 157(6):495-505. PubMed ID: 17228848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and prognostic value of Duke's Activity Status Index along with plasma B-type natriuretic peptide levels in chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Parissis JT; Nikolaou M; Birmpa D; Farmakis D; Paraskevaidis I; Bistola V; Katsoulas T; Filippatos G; Kremastinos DT
    Am J Cardiol; 2009 Jan; 103(1):73-5. PubMed ID: 19101233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decrease of plasma N-terminal pro beta-type natriuretic peptide as a predictor of clinical improvement after cardiac resynchronization therapy for heart failure.
    Ding LG; Hua W; Zhang S; Chu JM; Chen KP; Wang Y; Wang FZ; Chen X
    Chin Med J (Engl); 2009 Mar; 122(6):617-21. PubMed ID: 19323922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B-type natriuretic peptide as a predictor of postoperative heart failure after aortic valve replacement.
    Nozohoor S; Nilsson J; Lührs C; Roijer A; Algotsson L; Sjögren J
    J Cardiothorac Vasc Anesth; 2009 Apr; 23(2):161-5. PubMed ID: 19167912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated B-type natriuretic peptide level: use with caution in patients with multiple co-morbidities and presenting with dyspnea.
    Jeevanantham V; Shrivastava R; Nannapaneni S; Khan A; Sengodan M; Nautiyal A; Navaneethan S; Hsi D
    Indian Heart J; 2007; 59(1):64-8. PubMed ID: 19098338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered sodium intake affects plasma concentrations of BNP but not proBNP in healthy individuals and patients with compensated heart failure.
    Damgaard M; Goetze JP; Norsk P; Gadsbøll N
    Eur Heart J; 2007 Nov; 28(22):2726-31. PubMed ID: 17942579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
    Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
    Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-type natriuretic peptide predicts benefit from a home-based nurse care in chronic heart failure.
    Moertl D; Berger R; Hammer A; Huelsmann M; Hutuleac R; Pacher R
    J Card Fail; 2009 Apr; 15(3):233-40. PubMed ID: 19327625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Values of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in evaluation of cardiac function in children with congenital heart disease].
    Zhang SR; Zhang YH; Xu Q; Qiu HX; Chen Q
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jun; 11(6):429-32. PubMed ID: 19558803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Could B-type Natriuretic Peptide (BNP) plasma concentration be useful to predict fluid responsiveness [corrected] in critically ill patients with acute circulatory failure?
    Muller L; Louart G; Teboul JL; Mahamat A; Polge A; Bertinchant JP; Ripart J; de La Coussaye JE; Lefrant JY
    Ann Fr Anesth Reanim; 2009 Jun; 28(6):531-6. PubMed ID: 19524395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials.
    Felker GM; Hasselblad V; Hernandez AF; O'Connor CM
    Am Heart J; 2009 Sep; 158(3):422-30. PubMed ID: 19699866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does clinician's knowledge of B-type natriuretic peptide levels translate to improvement of quality of life and less hospitalization days in patients with heart failure?
    Ancheta IB; Evans M; Miller AB; Chiong JR; Battie C
    Prog Cardiovasc Nurs; 2009 Mar; 24(1):12-8. PubMed ID: 19261138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure.
    Cohen-Solal A; Logeart D; Huang B; Cai D; Nieminen MS; Mebazaa A
    J Am Coll Cardiol; 2009 Jun; 53(25):2343-8. PubMed ID: 19539144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimum blood collection intervals for B-type natriuretic peptide testing in patients with heart failure.
    Wu AH; Smith A; Apple FS
    Am J Cardiol; 2004 Jun; 93(12):1562-3. PubMed ID: 15194039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.